<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; recurrence</title>
	<atom:link href="http://oralcancernews.org/wp/tag/recurrence/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Tue, 27 Jul 2010 19:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Study suggests VELscope can help reduce recurrence of oral cancer</title>
		<link>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/#comments</comments>
		<pubDate>Fri, 19 Feb 2010 05:37:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[lesions]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[VELscope]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7908</guid>
		<description><![CDATA[
			
				
			
		
Source: www.dentaleconomics.com
Author: staff
LED Dental has announced a recent study suggests that its VELscope screening system can help surgeons reduce the recurrence rate for oral cancer following surgery. The article, &#8220;Tracing the &#8216;At-Risk&#8217; Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact,&#8221; was just published in the journal, Cancer Prevention Research. The article was was authored [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients</title>
		<link>http://oralcancernews.org/wp/genetic-variations-indicate-risk-of-recurrence-secondary-cancer-among-head-and-neck-cancer-patients/</link>
		<comments>http://oralcancernews.org/wp/genetic-variations-indicate-risk-of-recurrence-secondary-cancer-among-head-and-neck-cancer-patients/#comments</comments>
		<pubDate>Wed, 09 Dec 2009 01:30:22 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[genetic variations]]></category>
		<category><![CDATA[micro RNA]]></category>
		<category><![CDATA[miRNA]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7561</guid>
		<description><![CDATA[
			
				
			
		
Source: www.eurekalert.org
Author:  public release
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.
The team [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/genetic-variations-indicate-risk-of-recurrence-secondary-cancer-among-head-and-neck-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A 25-year analysis of veterans treated for tonsillar squamous cell carcinoma</title>
		<link>http://oralcancernews.org/wp/a-25-year-analysis-of-veterans-treated-for-tonsillar-squamous-cell-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/a-25-year-analysis-of-veterans-treated-for-tonsillar-squamous-cell-carcinoma/#comments</comments>
		<pubDate>Sat, 28 Nov 2009 14:59:15 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[smoking status]]></category>
		<category><![CDATA[surgery]]></category>
		<category><![CDATA[surgical]]></category>
		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7456</guid>
		<description><![CDATA[
			
				
			
		
Source: Arch Otolaryngol Head Neck Surg, November 1, 2009; 135(11)
Authors: JJ Jaber et al.
Objective:
To determine the recurrence and survival outcome based on treatment date, type of treatment, stage of disease, and comorbidity and the recurrence and survival differences based on smoking status as a surrogate for human papillomavirus status in veterans treated for tonsillar squamous [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/a-25-year-analysis-of-veterans-treated-for-tonsillar-squamous-cell-carcinoma/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Post-treatment pain in head and neck cancer patients may be associated with recurrence, lower survival rate</title>
		<link>http://oralcancernews.org/wp/post-treatment-pain-in-head-and-neck-cancer-patients-may-be-associated-with-recurrence-lower-survival-rate/</link>
		<comments>http://oralcancernews.org/wp/post-treatment-pain-in-head-and-neck-cancer-patients-may-be-associated-with-recurrence-lower-survival-rate/#comments</comments>
		<pubDate>Wed, 19 Aug 2009 00:58:16 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[post-treatment pain]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[recurrent disease]]></category>
		<category><![CDATA[survival rate]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6419</guid>
		<description><![CDATA[
			
				
			
		
Source: www.medicalnewstoday.com
Author: staff
Patients with head and neck cancer who experience a higher level of post-treatment pain appear to have a lower survival rate than those who experience little or no post-treatment pain, according to a report in the August issue of Archives of Otolaryngology-Head &#038; Neck Surgery, one of the JAMA/Archives journals. 
&#8220;Pain is an [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/post-treatment-pain-in-head-and-neck-cancer-patients-may-be-associated-with-recurrence-lower-survival-rate/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study suggests VELscope System helps reduce recurrence of oral cancer</title>
		<link>http://oralcancernews.org/wp/study-suggests-velscope-system-helps-reduce-recurrence-of-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/study-suggests-velscope-system-helps-reduce-recurrence-of-oral-cancer/#comments</comments>
		<pubDate>Sun, 26 Jul 2009 18:09:58 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[FV-guided surgery]]></category>
		<category><![CDATA[M.D. Anderson Cancer Center]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[VELscope]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6345</guid>
		<description><![CDATA[
			
				
			
		
Source: www.prweb.com
Author: press release
LED Dental Inc. announced today that a recent study suggests that its VELscope screening system can help surgeons reduce the recurrence rate for oral cancer following surgery. 
The article, &#8220;Tracing the &#8216;At-Risk&#8217; Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact,&#8221; was just published in the journal Cancer Prevention Research. It was [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/study-suggests-velscope-system-helps-reduce-recurrence-of-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The prognostic significance of histological features in oral squamous cell carcinoma</title>
		<link>http://oralcancernews.org/wp/the-prognostic-significance-of-histological-features-in-oral-squamous-cell-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/the-prognostic-significance-of-histological-features-in-oral-squamous-cell-carcinoma/#comments</comments>
		<pubDate>Sat, 04 Jul 2009 00:40:45 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[floor of mouth]]></category>
		<category><![CDATA[lateral tongue]]></category>
		<category><![CDATA[nodal metastasis]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6176</guid>
		<description><![CDATA[
			
				
			
		
Source: J Oral Pathol Med,  June 25, 2009
Authors: S R Larsen et al.
Background:
Different factors predict nodal metastasis, recurrence and survival in oral cancer. The aim was to assess the prognostic value of histological features related to the primary tumour. 
Methods:
A total of 144 patients surgically treated at Odense University Hospital for oral cancer between [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/the-prognostic-significance-of-histological-features-in-oral-squamous-cell-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral rinses used for tracking HPV-positive head and neck cancers hold promise for screening</title>
		<link>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/</link>
		<comments>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/#comments</comments>
		<pubDate>Sun, 28 Dec 2008 14:55:56 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[oral rinse]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=909</guid>
		<description><![CDATA[
			
				
			
		
Source: American Association for Cancer Research
Author: staff
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.
In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review</title>
		<link>http://oralcancernews.org/wp/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/</link>
		<comments>http://oralcancernews.org/wp/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/#comments</comments>
		<pubDate>Sun, 16 Nov 2008 18:17:31 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[concurrent chemotherapy]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[re-irradiation]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=725</guid>
		<description><![CDATA[
			
				
			
		
Source: Clin Otolaryngol, August 1, 2008; 33(4): 331-7
Authors: V Paleri and CG Kelly
Objectives:
Local recurrence is the major cause of treatment failure in head and neck cancer patients after radiation or combined therapy. If surgically unresectable, management involves supportive care or chemotherapy with palliative intent. Recent studies have assessed the role of re-irradiating these patients with [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/re-irradiation-with-concurrent-chemotherapy-in-recurrent-head-and-neck-cancer-a-decision-analysis-model-based-on-a-systematic-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Challenges in cancer survivorship</title>
		<link>http://oralcancernews.org/wp/challenges-in-cancer-survivorship/</link>
		<comments>http://oralcancernews.org/wp/challenges-in-cancer-survivorship/#comments</comments>
		<pubDate>Thu, 25 Sep 2008 19:43:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chronic inflammation]]></category>
		<category><![CDATA[Office of Cancer Survivorship]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[survivors]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=419</guid>
		<description><![CDATA[
			
				
			
		
Source: CURE Magazine (www.curetoday.com)
Author: Kathy LaTour
When Julia Rowland, PhD, director of the Office of Cancer Survivorship at the National Cancer Institute, took the stage in Atlanta at the fourth biennial cancer survivorship research conference in June, she welcomed the more than 450 participants on behalf of the estimated 12 million cancer survivors in the country [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/challenges-in-cancer-survivorship/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Disease-Free Period Predicts Response to Salvage Therapy for Oral Cancer</title>
		<link>http://oralcancernews.org/wp/disease-free-period-predicts-response-to-salvage-therapy-for-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/disease-free-period-predicts-response-to-salvage-therapy-for-oral-cancer/#comments</comments>
		<pubDate>Fri, 01 Aug 2008 12:05:07 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[EGFR-positive]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=162</guid>
		<description><![CDATA[
			
				
			
		
Source: Abkhazia (www.abkhazia.com)
Author: Ramaz Mitaishvili
In patients with locally recurrent carcinomas of the oral cavity and oropharynx, a disease-free interval of more than 1 year and tumor tissue negative for EGFR (epidermal growth factor receptor) expression predict a good response to salvage surgery.
That&#8217;s the conclusion of physicians in Brazil who studied the outcomes of 111 patients [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/disease-free-period-predicts-response-to-salvage-therapy-for-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
